In all, 12 patients were neutropenic (microl) at baseline, 10 received steroids and 16 calcineurin inhibitors or sirolimus.
Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus.
Revascularization rates were similar with the sirolimus - and paclitaxel-eluting stents in the two trials, at 5.6% versus 5.3%, respectively.
Clinical use of domestic sirolimus-eluting stents in the treatment of acute ST-elevation myocardial infarction
